Bronchodilator Response in Patients With Normal Baseline Spirometry

References

1. 1.↵
   National Asthma Education and Prevention Program. Expert panel report 3: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung, and Blood Institute; 2007. NIH publication no. 08-4051. www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed July 16, 2012.
2. 2.↵
   1. Rabe KF,
   2. Hurd S,
   3. Anzueto A,
   4. Barnes PJ,
   5. Buist SA,
   6. Calverley P,
   7. et al

   . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176(6):532–555.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Lorber DB,
   2. Kaltenborn W,
   3. Burrows B

   . Responses to isoproterenol in a general population sample. Am Rev Respir Dis 1978;118(5):855–861.

   OpenUrlPubMedWeb of Science
4. 4.↵
   1. Dales RE,
   2. Spitzer WO,
   3. Tousignant P,
   4. Schechter M,
   5. Suissa S

   . Clinical interpretation of airway response to a bronchodilator. Epidemiologic considerations. Am Rev Respir Dis 1988;138(2):317–320.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Lehmann S,
   2. Bakke PS,
   3. Eide GE,
   4. Humerfelt S,
   5. Gulsvik A

   . Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to a beta2-agonist. Pulm Pharmacol Ther 2006;19(4):272–280.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Johannessen A,
   2. Omenaas ER,
   3. Bakke PS,
   4. Gulsvik A

   . Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005;60(10):842–847.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Kainu A,
   2. Lindqvist A,
   3. Sarna S,
   4. Lundback B,
   5. Sovijarvi A

   . FEV₁ response to bronchodilation in an adult urban population. Chest 2008;134(2):387–393.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Pellegrino R,
   2. Viegi G,
   3. Brusasco V,
   4. Crapo RO,
   5. Burgos F,
   6. Casaburi R,
   7. et al

   . Interpretative strategies for lung function tests. Eur Respir J 2005;26(5):948–968.

   OpenUrlFREE Full Text
9. 9.↵
   1. Townsend R,
   2. Hegewald M,
   3. Jensen R,
   4. Crapo R

   . Frequency of acute bronchodilator response in patients with normal lung function [abstract]. Am J Respir Crit Care Med 2009;179:A4423.

   OpenUrl
10. 10.↵
    1. Hankinson JL,
    2. Odencrantz JR,
    3. Fedan KB

    . Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999;159(1):179–187.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Enright PL,
    2. Beck KC,
    3. Sherrill DL

    . Repeatability of spirometry in 18,000 adult patients. Am J Respir Crit Care Med 2004;169(2):235–238.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Lange NE,
    2. Mulholland M,
    3. Kreider ME

    . Spirometry: don't blow it! Chest 2009;136(2):608–614.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Eliasson O,
    2. Degraff AC Jr.

    . The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables. Am Rev Respir Dis 1985;132(4):858–864.

    OpenUrlPubMedWeb of Science
14. 14.↵
    1. Cocchetto DM,
    2. Sykes RS,
    3. Spector S

    . Paradoxical bronchospasm after use of inhalation aerosols: a review of the literature. J Asthma 1991;28(1):49–53.

    OpenUrlPubMedWeb of Science
15. 15.
    1. Nicklas RA

    . Paradoxical bronchospasm associated with the use of inhaled beta agonists. J Allergy Clin Immunol 1990;85(5):959–964.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Yarbrough J,
    2. Mansfield LE,
    3. Ting S

    . Metered dose inhaler induced bronchospasm in asthmatic patients. Ann Allergy 1985;55(1):25–27.

    OpenUrlPubMedWeb of Science
17. 17.↵
    1. Quadrelli SA,
    2. Roncoroni AJ,
    3. Montiel GC

    . Evaluation of bronchodilator response in patients with airway obstruction. Respir Med 1999;93(9):630–636.

    OpenUrlPubMed
18. 18.
    1. Brand PL,
    2. Quanjer PH,
    3. Postma DS,
    4. Kerstjens HA,
    5. Koeter GH,
    6. Dekhuijzen PN,
    7. et al

    . Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Thorax 1992;47(6):429–436.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Meslier N,
    2. Racineux JL,
    3. Six P,
    4. Lockhart A

    . Diagnostic value of reversibility of chronic airway obstruction to separate asthma from chronic bronchitis: a statistical approach. Eur Respir J 1989;2(6):497–505.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Miller MR,
    2. Hankinson J,
    3. Brusasco V,
    4. Burgos F,
    5. Casaburi R,
    6. Coates A,
    7. et al

    ; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005;26(2):319–338.

    OpenUrlAbstract/FREE Full Text